Browsing Category
Funding &Trends
280 posts
Curexel Technologies: Making painless injections a reality
Backed by 7+ years of IISc research, Curexel Technologies is making needle-based treatments pain-free through microneedles, jet injection, and patient-first innovation.
Should AI chatbots be treating children’s mental health?
AI therapy tools promise mental health support for kids, but at what cost? Discover the ethical concerns about attachment risks, bias, lack of regulation and the urgent need for safeguards.
Consumer healthtech: From trend to revolution
Galen Growth’s analysis reveals how Consumer HealthTech is evolving into a healthcare revolution. Discover funding surges, clinical validation, and key players.
Insights from HLTH Europe 2025: Top healthtech trends, key takeaways and more
New market maps, AI advancements, the push for a consumer-centric health ecosystem and much more.
Moonshot Mixers: No pitches, no panel, just raw conversations about the future of healthtech
A new kind of gathering for the boldest minds in healthtech
8 healthtech startups that made it to CB Insights AI 100 list
Here are CB Insights' 8 innovative AI healthcare startups redefining patient care, diagnostics, and clinical workflows across global markets.
WHO World Health Statistics 2025: How healthy is the world, really?
The 2025 report depicts current global health trends, progress in well-being and persistent gaps in healthcare access and emergency preparedness.
Is OpenAI’s HealthBench setting a new standard for healthcare AI?
OpenAI’s HealthBench is a doctor-approved dataset to advance AI safety in healthcare. Explore its role in improving AI communication and context for future health applications.
Here’s everything that happened at HIMSS25 Europe
Uncover HIMSS25 Europe conference's core themes, major takeaways, and the path to a more connected and secure digital health future.
Oura vs Ultrahuman patent battle complete details (updated)
Oura’s early win in the Oura vs Ultrahuman patent battle could block Ultrahuman’s smart ring from entering the US market.